Equistar

Equistar (Shanghai Equistar Biotech) is a biotechnology company specializing in the development and commercialization of exosome-based diagnostic and therapeutic technologies. The company leverages its proprietary Exo-P platform for high-purity exosome isolation and multi-omic analysis to develop non-invasive liquid biopsy tests for early cancer detection and monitoring. Equistar's product portfolio includes specialized research kits and clinical diagnostic assays targeting various malignancies, including lung, gastric, and liver cancers. Based in Shanghai, the company collaborates extensively with clinical institutions and the National Engineering Center for Biochip to integrate exosome technology into precision medicine workflows.